Chutes & Ladders—Bristol Myers' research chief out amid R&D reorganization

Bristol Myers Squibb's research chief is departing as the company restructures R&D. Summit Therapeutics cut ties with multiple launch team members, including its CCO, ahead of a high-stakes FDA decision. And OncoNano appointed its interim chief, a former FDA commissioner, to the permanent CEO spot.